In 2023, Thomas Gad earned $1.11M in total compensation at Y-mAbs Therapeutics, Inc., including $664.90K salary and $362.37K bonus. Most recently sold 21,620 shares in Mar 2025. Currently holds stock worth $12.09M. Has donated $585.48K in stock to charitable causes. Led Y-mAbs Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Thomas Gad, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.11M
Salary
$664.90K
Bonus
$362.37K
Other
$84.36K
Salary
$664.90KBoard Justification
The compensation philosophy aims to attract, retain, and motivate superior executive talent while aligning executives' interests with those of stockholders through performance-based incentives.
Bonus
$362.37KBoard Justification
Performance-based annual cash incentive compensation based on achieving predetermined performance targets for 2023, resulting in a payout percentage of 109% of the target bonus.
Other Compensation
$84.36KBoard Justification
Other compensation includes a monthly housing allowance and accident insurance premiums.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus was on cash compensation and options granted.
Performance Metrics
Performance metrics include financial and operational targets aligned with the company's long-term goals.
Thomas Gad
Founder and Ex-CEO of Y-mAbs Therapeutics, Inc.
Education
MBA from Harvard Business School
Field of Expertise
Business & Management - Business Development
Sector of Economy
Healthcare
Born
January 1, 1962 - 63 years ago
CEO of Y-mAbs Therapeutics, Inc. for
1 year 6 months (Apr 2022 - Nov 2023)
Previous Experience
Founder of Y-mAbs Therapeutics, Inc. and has extensive experience in business development and strategy in the biopharmaceutical industry.
Other Y-mAbs Therapeutics, Inc. CEOs
Holdings
Track Thomas Gad's stock holdings and portfolio value over time.
Total Stock Sold
$47.40M
$47.40M
2,402,766 YMAB shares
What if they kept their stock?
If Thomas Gad didn't sell their stock, today they would have:
Extra YMAB2,402,766 shares worth $20.69M.
This is -56.35% and $26.71M less than what they got when they sold the stock.
Charitable Transactions
68,000 shares
YMAB
Recent Charitable Transactions
60,000 shares
YMAB
Dec 14, 2021
Charity
8,000 shares
YMAB
Dec 13, 2019
Charity
Insider Trading
Thomas Gad's recent stock transactions, purchases, and sales filed with the SEC.
$113.07K
YMAB at $5.23/share
Mar 7, 2025
Sale
32,000 shares
YMAB
Jan 17, 2025
Received
$1.26M
YMAB at $13.22/share
Sep 13, 2024
Sale
$841.05K
YMAB at $12.02/share
Jun 10, 2024
Sale
$404.39K
YMAB at $12.50/share
May 21, 2024
Sale
$64.12K
YMAB at $16.44/share
Mar 5, 2024
Sale
22,100 shares
YMAB
Jan 18, 2024
Received
$1.00M
YMAB at $6.67/share
Dec 13, 2023
Sale
$795.38K
YMAB at $5.30/share
Nov 20, 2023
Sale
40,500 shares
YMAB
Jan 17, 2023
Received
Rivals
Compare Thomas Gad with competitor CEOs and industry peers.